Palladium-103
From Wikipedia, the free encyclopedia
Palladium-103 is a radioisotope of the element palladium which has uses in radiation therapy for prostate cancer and ocular melanoma. Palladium-103 may be created from palladium-102. It has a half-life of 17 days and decays by electron capture to rhenium-103, emitting x-rays with 21 keVs of energy.
[edit] References
- Patent application for Palladium-103 implantable radiation-delivery device (accessed 12/7/05)